65.41
-0.24
(-0.37%)
At close: 5:32:18 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 4 | 6 | 10 |
| Avg. Estimate | 13.79B | 16.57B | 62.35B | 65.79B |
| Low Estimate | 13.33B | 16.05B | 60.54B | 63.53B |
| High Estimate | 14.3B | 17.35B | 64.17B | 69.4B |
| Year Ago Sales | 13.75B | 16.66B | 61.64B | 62.35B |
| Sales Growth (year/est) | 0.34% | -0.51% | 1.15% | 5.51% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DAL.VI | -- | -- | -- | -- |
| S&P 500 | 9.39% | 11.29% | 14.06% | 13.54% |
Upgrades & Downgrades
| Maintains | Susquehanna: Positive to Positive | 1/7/2025 |
| Maintains | Citigroup: Buy to Buy | 11/26/2024 |
| Maintains | Deutsche Bank: Buy to Buy | 11/21/2024 |
| Maintains | Barclays: Overweight to Overweight | 11/14/2024 |
| Maintains | TD Cowen: Buy to Buy | 11/12/2024 |
| Maintains | Jefferies: Buy to Buy | 11/11/2024 |